References
- Tefferi A, Vardiman JW. Classification and diagnosis of myeloproliferative neoplasm: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008; 22: 2118–2119
- Barbui T, Finazzi G. Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia. Curr Hematol Rep. May 2003; 2(3)248–256
- Kutti J, Ridell B. Epidemiology of the myeloproliferative disorders: Essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis. Pathol Biol (Paris) 2001; 49(2)164–166
- Gugliotta L, Marchioli R, Fiacchini M, Vianelli N, Baravelli S, Val-dre L. Epidemiological, diagnostic, therapeutic and prognostic aspects of essential thrombocythemia in a retrospective study of GIMMC in two thousand patients. Blood 1997; 90: 348a
- Landgren O, Goldin L, Kristinsson S, Helgadottir E, Samuelsson J, Björkholm M. Increased risks of polycythemia vera, essential thrombocythemia, and myelofibrosis among 24 577 first-degree relatives of 11 039 patients with myeloproliferative neoplasms in Sweden. Blood 2008; 112: 2199–2204
- Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004; 5: 283–291
- Barbui T, Barosi G, Grossi A, Gugliotta L, Liberato LN, Marchetti M, Mazzucconi MG, Rodeghiero F, Tura S. Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematolgy and the Italian Group for Bone Marrow Transplantation. Haematologica 2004; 89: 215–232
- Harrison C. Pregnancy and its management in the Philadelphia negative myeloproliferative diseases. Br J Haematol 2005; 129: 293–306
- Gangat N, Wolanskyj AP, Schwager S, Tefferi A. Predictors of pregnancy outcome in essential thrombocythemia: A single institution study of 63 pregnancies. Eur J Haematol 2009; 82: 350–353
- Griesshammer M, Struve S, Harrison CM. Essential thrombocythemia/ polycythemia vera and pregnancy: The need for an observational study in Europe. Semin Thromb Hemost. 2006; 32: 422–429
- Elliott MA, Tefferi A. Thrombocythaemia and pregnancy. Best Pract Res Clin Hematol. 2003; 16: 227–242
- Passamonti F, Rumi E, Randi ML, Morra E, Cazzola M. Aspirin in pregnant patients with essential thrombocythemia: A retrospective analysis of 129 pregnancies. J Thromb Haemost 2010; 8: 411–413
- Vantroyen B, Vanstraelen D. Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. Acta Haematol 2002; 107: 158–169
- Ruggeri M, Finazzi G, Tosetto A, Riva S, Rodeghiero F, Barbui T. No treatment for low-risk thrombocythaemia: Results from a prospective study. Br J Haematol 1998; 103: 772–777
- Delage R, Demers C, Cantin G, Roy J. Treatment of essential thromobocythemia during pregnancy with interferon-alpha. Obstet Gynecol 1996; 87: 814–817
- Williams JM, Schlesinger PE, Gray AG. Successful treatment of essential thrombocythaemia and recurrent abortion with alpha interferon. Br J Haematol 1994; 88: 647–648
- Petit JJ, Callis M, Fernandez de Sevilla A. Normal pregnancy in a patient with essential thrombocythemia treated with interferonalpha 2b [letter]. Am J Hematol 1992; 40: 80
- Pardini S, Dore F, Murineddu M, Bontigli S, Longinotti M, Grigliotti B, Spano B. Alpha 2b-interferon therapy and pregnancy report of a case of essential thrombocythemia [letter]. Am J Hematol 1993; 43: 78–79
- Demmers KJ, Derecka K, Flint A. Trophoblast interferon and pregnancy. Reproduction 2001; 121: 41–49
- Pons JC, Lebon P, Frydman R, Delfraissy JF. Pharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage. Fetal Diagn Ther 1995; 10: 7–10
- Melillo L, Tieghi A, Candoni A. Outcome of 122 pregnancies in essential thrombocythemia patients: A report from the Italian registry. Am J haematol 2009; 84: 636–640